Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Nadia Habel

1PUBLICATIONS

5CO-AUTHORS

Haematological tumours

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (1)

Sort by Publication Date:

|Nov 20, 2019

HVEM has a broader expression than PD-L1 and constitutes a negative prognostic marker and potential treatment target for melanoma.

Nausicaa Malissen, Nicolas Macagno, Samuel Granjeaud

Pageof 1

Frequent Collaborators

1 joint publications

Nausicaa Malissen

1 joint publications

Nicolas Macagno

1 joint publications

Samuel Granjeaud

1 joint publications

Caroline Gaudy-Marqueste

1 joint publications

Robert Ballotti

Frequent Collaborators

1 joint publications

Nausicaa Malissen

1 joint publications

Nicolas Macagno

1 joint publications

Samuel Granjeaud

1 joint publications

Caroline Gaudy-Marqueste

Top Related Videos

Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology

Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology

Published on : May 02, 2025

See more related videos

Top Related Videos

Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology

Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology

Published on : May 02, 2025

See more related videos